The Cervical Cancer Screening Laboratory will continue to process any Pap samples it receives, and primary care providers will continue to receive results.
Colposcopy clinics are triaging follow-up procedures and deferring procedures based on service priorities.
Patients with significant symptoms including post coital bleeding, persistent intermenstrual bleeding and/or a persistent vaginal discharge that cannot be explained by benign causes such as infection should have a speculum examination by someone with experience in cervical disease. Referral to a colposcopist is appropriate and may be expedited if the clinical suspicion is high. A Pap test is not required for referral.
Patients who have been recommended for colposcopy should still be referred. As colposcopy services may be limited during the COVID-19 pandemic, colposcopy clinics will prioritize colposcopy examinations based on risk estimation.
The need for follow-up Pap tests for previous mild abnormalities (ASC-US and LSIL) should be considered in the context of the ongoing pandemic.